BioCentury
ARTICLE | Finance

Nov. 11 Quick Takes: Crossovers back Acrivon in $100M series B

Plus: Vaxxinity raises $78M, BMS invests in Compugen, Pharmacosmos and more

November 12, 2021 2:04 AM UTC

A syndicate led by Wellington Management Co. and Citadel’s Surveyor Capital has backed Acrivon Therapeutics Inc. with $100 million in series B funding that will allow the biotech to conduct ...



Access this Article